Double maintains 3 strategies that include NTLA - Intellia Therapeutics, Inc.
Current Value
$8.501 Year Return
Current Value
$8.501 Year Return
Name | Correlation | AUM | Expense Ratio |
---|---|---|---|
GNOM | 72.87% | $57.10M | 0.5% |
ARKG | 68.64% | $1.07B | 0.75% |
RSPA | 66.68% | $280.76M | 0% |
CPRJ | 62.72% | $48.98M | 0.69% |
XBI | 61.56% | $5.66B | 0.35% |
IBB | 60.73% | $6.06B | 0.45% |
IWC | 57.37% | $845.76M | 0.6% |
VTWO | 55.15% | $11.13B | 0.07% |
IWM | 55.13% | $65.55B | 0.19% |
IWO | 55.05% | $11.19B | 0.24% |
BBH | 54.64% | $400.47M | 0.35% |
SCHA | 54.62% | $16.35B | 0.04% |
PBE | 54.35% | $240.72M | 0.58% |
NUSC | 53.86% | $1.14B | 0.31% |
KJAN | 53.66% | $322.85M | 0.79% |
ESML | 53.56% | $1.79B | 0.17% |
GSSC | 53.38% | $520.64M | 0.2% |
FBT | 52.91% | $1.12B | 0.56% |
KOMP | 52.87% | $2.03B | 0.2% |
IWN | 52.65% | $11.31B | 0.24% |
Name | Correlation | Market Cap | Return % (1 Year) | Div Yield % |
---|---|---|---|---|
CRSP | 63.51% | $3.53B | -44.74% | 0.00% |
BEAM | 61.22% | $2.28B | -34.56% | 0.00% |
RXRX | 58.25% | $2.60B | -39.15% | 0.00% |
FATE | 56.57% | $107.34M | -87.39% | 0.00% |
ABCL | 55.58% | $709.21M | -49.47% | 0.00% |
ALLO | 54.90% | $354.14M | -62.79% | 0.00% |
RCKT | 53.30% | $887.16M | -69.97% | 0.00% |
DNLI | 51.78% | $2.12B | -30.43% | 0.00% |
SDGR | 51.72% | $1.63B | -19.01% | 0.00% |
ARWR | 51.26% | $2.07B | -46.48% | 0.00% |
KN | 49.44% | $1.41B | +3.47% | 0.00% |
VSH | 48.05% | $2.33B | -22.72% | 2.37% |
RGNX | 47.35% | $418.72M | -62.84% | 0.00% |
LFUS | 46.27% | $5.22B | -8.66% | 1.29% |
DIOD | 46.09% | $2.12B | -33.96% | 0.00% |
CRBU | 45.55% | $93.00M | -80.95% | 0.00% |
AEIS | 45.24% | $3.99B | +8.06% | 0.38% |
BN | 45.19% | $88.51B | +26.98% | 0.62% |
JOE | 45.16% | $2.73B | -18.07% | 1.17% |
RRX | 44.89% | $8.19B | -32.26% | 1.16% |
Name | Correlation | AUM | Expense Ratio |
---|---|---|---|
DBA | -0.25% | $845.19M | 0.93% |
SGOV | -0.35% | $38.60B | 0.09% |
CLOA | 0.44% | $779.45M | 0.2% |
FTGC | -0.65% | $2.51B | 1.02% |
DUSB | 0.73% | $1.13B | 0.15% |
UNG | 0.94% | $456.14M | 1.06% |
DBC | -0.94% | $1.33B | 0.87% |
USFR | 0.97% | $18.45B | 0.15% |
EQLS | 1.00% | $6.31M | 1% |
USCI | -1.19% | $228.07M | 1.07% |
IVOL | 1.42% | $459.41M | 1.02% |
BUXX | 1.52% | $229.45M | 0.25% |
PDBC | -1.94% | $4.85B | 0.59% |
TFLO | 2.20% | $6.79B | 0.15% |
WEAT | -2.51% | $122.51M | 0.28% |
TBLL | -3.15% | $2.05B | 0.08% |
JUCY | 3.18% | $305.26M | 0.6% |
GBIL | 3.45% | $6.15B | 0.12% |
AGZD | -3.48% | $139.24M | 0.23% |
XHLF | -3.57% | $1.06B | 0.03% |
Name | Correlation | Market Cap | Return % (1 Year) | Div Yield % |
---|---|---|---|---|
SITC | 0.24% | $671.11M | +13.38% | 1.03% |
FRO | -0.25% | $3.76B | -27.99% | 10.73% |
WELL | 0.30% | $94.84B | +58.85% | 1.78% |
CYCN | -0.37% | $7.34M | -15.31% | 0.00% |
DKL | -0.41% | $2.34B | +6.86% | 10.05% |
EXC | -0.43% | $44.82B | +20.42% | 3.46% |
NOC | -0.63% | $70.82B | +4.65% | 1.68% |
XGN | 0.65% | $66.04M | +120.96% | 0.00% |
HCI | 0.74% | $1.48B | +18.34% | 1.17% |
WST | 0.80% | $16.45B | -42.53% | 0.36% |
AMSF | -0.81% | $981.28M | +7.61% | 2.91% |
ACGL | 0.95% | $34.70B | +7.20% | 0.00% |
PRA | 1.06% | $1.18B | +85.65% | 0.00% |
ABBV | -1.07% | $374.18B | +19.41% | 2.97% |
TRVG | -1.10% | $107.67M | +82.95% | 0.00% |
CL | -1.13% | $73.27B | +1.70% | 2.22% |
MOH | -1.17% | $17.50B | -24.53% | 0.00% |
PG | 1.19% | $392.88B | +3.52% | 2.40% |
ALL | 1.19% | $55.70B | +29.60% | 1.80% |
FE | 1.21% | $22.96B | +4.02% | 4.29% |
Finnhub
Faruqi & Faruqi, LLP Securities Litigation Partner James Wilson Encourages Investors Who Suffered Losses Exceeding $50,000 In Intellia To Contact Him Directly To Discuss Their OptionsIf you suffered...
Finnhub
LOS ANGELES, March 21, 2025 /PRNewswire/ -- The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Intellia Therapeutics, Inc. for...
Finnhub
NEW YORK, March 21, 2025 /PRNewswire/ -- Levi & Korsinsky, LLP notifies investors in Intellia Therapeutics, Inc. of a class action securities lawsuit. ...
Finnhub
NEW YORK, March 20, 2025 /PRNewswire/ -- The Gross Law Firm issues the following notice to shareholders of Intellia Therapeutics, Inc. . ...
Finnhub
NEW YORK, March 19, 2025 /PRNewswire/ -- Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Intellia Therapeutics, Inc. between July 30, 2024 and January 8, 2025,...
Finnhub
NEW YORK, March 18, 2025 /PRNewswire/ -- Levi & Korsinsky, LLP notifies investors in Intellia Therapeutics, Inc. of a class action securities lawsuit. ...
Name | Correlation | Market Cap | Return % (1 Year) | Div Yield % |
---|---|---|---|---|
CBOE | -16.03% | $22.97B | +19.12% | 1.11% |
CME | -13.98% | $96.05B | +23.35% | 3.94% |
VHC | -11.24% | $35.27M | +26.25% | 0.00% |
HUSA | -8.38% | $16.94M | -20.59% | 0.00% |
EQNR | -7.06% | $69.24B | +0.07% | 5.45% |
EDR | -6.75% | $9.39B | +13.50% | 0.83% |
TMUS | -6.67% | $293.46B | +59.72% | 1.20% |
K | -6.47% | $28.42B | +46.73% | 2.76% |
PSQH | -6.17% | $116.30M | -44.12% | 0.00% |
BTCT | -5.94% | $23.17M | +40.12% | 0.00% |
TCTM | -5.57% | $3.22M | -84.87% | 0.00% |
LRN | -4.78% | $5.35B | +93.84% | 0.00% |
LFVN | -4.65% | $204.34M | +134.92% | 0.99% |
CHD | -4.45% | $26.58B | +4.03% | 1.06% |
INSM | -4.43% | $14.26B | +199.05% | 0.00% |
ED | -4.10% | $38.30B | +22.37% | 3.09% |
NEUE | -3.34% | $43.50M | -18.92% | 0.00% |
T | -3.25% | $192.30B | +56.12% | 4.14% |
CCEC | -3.15% | $1.14B | +9.37% | 3.06% |
BACK | -3.02% | $1.41M | -67.43% | 0.00% |
Name | Correlation | AUM | Expense Ratio |
---|---|---|---|
BTAL | -46.68% | $392.24M | 1.43% |
VIXY | -31.26% | $195.31M | 0.85% |
TAIL | -23.67% | $83.83M | 0.59% |
USDU | -19.74% | $214.47M | 0.5% |
UUP | -15.61% | $332.64M | 0.77% |
UGA | -13.30% | $85.26M | 0.97% |
CTA | -11.56% | $927.03M | 0.76% |
KMLM | -8.45% | $227.79M | 0.9% |
DBE | -8.29% | $54.72M | 0.77% |
DBO | -7.63% | $190.57M | 0.77% |
USO | -7.19% | $891.33M | 0.6% |
TPMN | -7.18% | $33.27M | 0.65% |
BNO | -6.99% | $90.64M | 1% |
BILZ | -6.51% | $720.70M | 0.14% |
USL | -4.74% | $45.36M | 0.85% |
CCOR | -4.43% | $63.91M | 1.18% |
OILK | -4.13% | $64.75M | 0.69% |
ULST | -4.12% | $584.04M | 0.2% |
COMT | -4.00% | $671.56M | 0.48% |
GSG | -3.86% | $1.03B | 0.75% |